Clinical Trials Logo

Filter by:
NCT ID: NCT01982240 Completed - Clinical trials for Chronic Idiopathic Constipation

12-Week Study of Plecanatide for CIC (The CIC3 Study)

Start date: November 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to confirm that the investigational medication, plecanatide, is safe and effective in treating chronic idiopathic constipation.

NCT ID: NCT01981889 Completed - Clinical trials for Inflammatory Bowel Disease 11

Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease

Start date: October 2013
Phase: Phase 4
Study type: Interventional

Steroid is commonly used to treat autoimmune disorders such as rheumatoid arthritis, lupus, and inflammatory bowel disease (Crohn's Disease and Ulcerative Colitis). However, its use is associated with numerous systemic side-effects, including diabetes, osteoporosis, and potentially significant mood changes. The investigators wish to determine how common patients with inflammatory bowel disease experience mood changes when they take steroid for their disease.

NCT ID: NCT01981850 Completed - Clinical trials for Primary Myelofibrosis

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

Start date: October 1, 2013
Phase: Phase 2
Study type: Interventional

RO7490677 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is the organ in the body that makes blood cells, is replaced by fibrosis, or excess scar tissue. The purpose of this study is to gather information on whether RO7490677 has an effect on the MF disease, whether it is safe in patients with MF, and how well it is tolerated.

NCT ID: NCT01981369 Completed - Postoperative Pain Clinical Trials

Effect of Intravenous Dexmedetomidine on Analgesic Duration of Infraclavicular Block

Start date: January 2014
Phase: N/A
Study type: Interventional

The study will evaluate the effect of Dexmedetomidine sedation on the duration of infraclavicular block in patients scheduled for surgery of elbow, forearm and/or hand. All patients will receive infraclavicular block before the surgery and then they will be randomized to receive either Dexmedetomidine or Propofol sedation. Duration of the sensory block will be evaluated in recovery room, 24 and 48 hours after the surgery. Hypothesis: Primary: Dexmedetomidine sedation increases the duration of sensory infraclavicular block in patients scheduled for upper limb surgery. Secondary: Dexmedetomidine sedation - Gives an adequate level of sedation during the surgical procedure - Reduces the requirements of postoperative opioids - Improves the quality of sleep on the night of the surgery - Increases patients satisfaction regarding the anesthesia technique - Dexmedetomidine sedation is safe and easy to use - Dexmedetomidine sedation provides less respiratory depression during the procedure.

NCT ID: NCT01981343 Completed - Gallbladder Clinical Trials

A Parallel Study Evaluating the Effect of A-F Betafood® on Gallbladder and Liver Function.

Start date: November 11, 2013
Phase: Phase 2
Study type: Interventional

Gallstone formation is multifactorial: immutable risk factors include genetics and ethnicity, age and being female, and mutable risk factors include obesity, and metabolic syndrome, diet, rapid weight loss, and other conditions such as cirrhosis, Crohn's disease, irritable bowel syndrome, gallbladder stasis, and the use of certain drugs like Ceftriazone. Previous studies have linked serum cholesterol, and low-density lipoprotein cholesterol levels and fatty liver disease to gallbladder disease. Given betaine's reported beneficial effects on fatty liver and lipid profile, A-F Betafood® may have a beneficial effect on gallbladder function. The objective of the study is to assess the effect of A-F Betafood® on gallbladder and liver function as measured by gallbladder ultrasounds and liver function tests. The hypothesis is that A-F Betafood® will improve gallbladder and liver function after the 12 week treatment period. This is a single-center, randomized, double-blind, placebo-controlled, parallel group study with two arms. This study will consist of a single 12 week treatment period. The planned sample size for this study is 50 overweight female subjects, with 25 subjects randomized equally to each of the two study arms in double-blind manner at a ratio of 1:1

NCT ID: NCT01981070 Completed - Stress Clinical Trials

Parent Supports Intervention Project

Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of two community based interventions for parents of adults with intellectual or developmental disabilities (IDD) who are requesting services. The two interventions will include: 1. Support and Information Intervention - provides parents with support and information about services for their sons and daughters 2. Mindfulness Intervention - empowers parents through teaching them mindfulness skills We hypothesize that: 1. Parents in both types of interventions will report benefits (reductions in psychological distress) maintained at follow-up. 2. Parents in mindfulness intervention group will report improvements in mindful parenting, self compassion, positive gain, empowerment, and reduced burden. Parents in support and information intervention group will report improvements in empowerment, positive gain, and reduced burden. 3. Parents in mindfulness intervention group will show greater improvements by 3 months follow-up than parents in the support and information group.

NCT ID: NCT01980927 Completed - Migraine Clinical Trials

Changes in Intracranial Compliance in Migraine Subjects Following a National Upper Cervical Chiropractic Association Atlas Correction

Start date: November 2011
Phase: N/A
Study type: Interventional

A small number of chiropractors, who align only the atlas C-1, or "top" vertebra in the spine, practice the National Upper Cervical Chiropractic Association (NUCCA) atlas correction procedure. This procedure uses a precise, non-invasive, gentle touch technique to correct misalignment of the atlas. Although NUCCA practitioners have long used this procedure in the treatment of headache, it has not been formally studied using clinical trials. There is some data indicating that NUCCA correction can increase intracranial compliance. This intracranial compliance can be measured by a magnetic resonance imaging (MRI) study before and then after a NUCCA procedure. In this study, the investigators hope to show that the correction of an atlas misalignment will increase intracranial compliance in subjects with migraine.

NCT ID: NCT01980914 Completed - Type 2 Diabetes Clinical Trials

Hypoglycemia (Low Blood Sugar) and the Heart

Start date: March 2015
Phase: N/A
Study type: Interventional

The risk of hypoglycemia (low blood sugar) associated with the treatment of diabetes increases with age. Hypoglycemia is a common reason for admission to hospital for older patients with diabetes. Older patients are often unaware that their blood sugar is low and asymptomatic hypoglycemia, as assessed by continuous blood sugar monitoring, is frequent in the elderly. There is also evidence that older people with diabetes are more likely to develop cardiovascular events such a heart attack and more likely to die suddenly when compared to older people without diabetes. It is possible that low blood sugar levels contribute to the increased frequency of these events, but this possibility has never been studied. The purpose of this study is to assess how frequently low blood sugar occurs in older patients with diabetes and to see if low blood sugars adversely affect heart function in these patients.

NCT ID: NCT01980511 Completed - Clinical trials for Covert Postoperative Stroke

Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN

NeuroVISION
Start date: March 24, 2014
Phase:
Study type: Observational

The NeuroVISION Study will characterize the incidence, impact, and risk factors of covert stroke in adults undergoing noncardiac surgery. We will determine the incidence of acute covert stroke using an MRI study of the brain in the days following noncardiac surgery. We will characterize the epidemiology and the impact of covert stroke in patients undergoing noncardiac surgery, and its association with cerebral deoxygenation.

NCT ID: NCT01980121 Completed - Pregnancy Clinical Trials

Gastric Sonography in the Fasted Term Pregnant Patient for Elective Cesarean Delivery

Start date: October 2013
Phase: N/A
Study type: Observational

Food residue in the stomach of patients scheduled to have surgery is considered a major risk factor for pulmonary aspiration of gastric contents. The resulting respiratory compromise after aspiration is associated with significant morbidity and mortality. The risk of pulmonary aspiration is especially important in pregnant women, as they may often require surgery without having observed appropriate fasting. In pregnant patients scheduled for elective surgery, standard preoperative guidelines apply as the general non-pregnant surgical population (8-hour fasting of solid food and 2-hour fasting of clear fluids). A bedside ultrasound assessment of the status of the gastric content and volume would be of great value for the clinician. This technique has recently been shown very promising in fasted non-pregnant patients scheduled for elective surgery. Therefore, it is important to study its feasibility in the pregnant population scheduled for elective Cesarean Delivery. The investigators hypothesize that no residual solid contents will be found in the gastric sonography, and a small volume of gastric fluid will be observed in the antrum in both supine and right lateral decubitus.